scanX
Home
Unichem Laboratories

Unichem Laboratories

848.50
-5.55
(-0.65%)
Market Cap (₹ Cr.)
₹6,013
52 Week High
937.95
Book Value
₹336
52 Week Low
400.55
PE Ratio
120.39
PB Ratio
2.51
PE for Sector
39.67
PB for Sector
4.00
ROE
-2.98 %
ROCE
-2.64 %
Dividend Yield
0.00 %
EPS
₹0.00
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
25.70 %
Net Income Growth
-65.13 %
Cash Flow Change
119.61 %
ROE
-64.10 %
ROCE
-73.36 %
EBITDA Margin (Avg.)
-1,588.24 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
260
315
311
310
307
343
368
201
191
182
247
2,731
249
221
278
272
306
261
254
254
235
260
321
325
266
213
222
263
286
257
276
267
314
353
341
440
406
399
444
Expenses
240
266
271
275
270
293
325
164
165
175
185
214
230
240
246
266
282
251
261
257
227
249
267
280
233
230
227
265
264
256
302
294
426
338
341
343
494
350
372
EBITDA
20
49
41
35
37
49
43
37
26
8
62
2,517
19
-19
32
6
24
10
-7
-3
8
11
54
45
33
-16
-5
-2
22
1
-25
-27
-113
14
0
97
-88
49
72
Operating Profit %
4 %
13 %
11 %
9 %
10 %
13 %
11 %
-5 %
-7 %
-24 %
-14 %
-34 %
-13 %
-19 %
-0 %
-9 %
-2 %
-8 %
-16 %
-11 %
-5 %
-3 %
14 %
10 %
11 %
-14 %
-5 %
-7 %
5 %
-4 %
-14 %
-17 %
-38 %
2 %
-2 %
5 %
-24 %
10 %
15 %
Depreciation
8
9
9
9
9
10
11
10
10
10
11
12
13
12
15
17
18
17
18
17
19
18
19
19
20
20
21
21
21
23
27
29
28
27
27
26
25
26
26
Interest
0
1
1
0
1
1
1
0
0
1
1
1
1
0
0
0
0
0
0
0
1
0
0
1
0
0
1
0
1
2
3
2
3
3
4
2
2
1
2
Profit Before Tax
12
40
31
26
27
39
32
27
15
-3
50
2,504
6
-32
17
-11
6
-7
-25
-20
-12
-8
35
26
12
-36
-27
-24
-0
-23
-55
-57
-144
-16
-31
69
-115
22
43
Tax
2
11
8
5
-1
10
8
-1
-4
-12
-6
6
-1
0
0
-1
0
0
0
0
0
0
5
-5
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
10
29
23
21
28
26
21
26
32
2
46
2,507
2
-21
15
4
10
1
-25
-20
-12
-8
30
30
1
-28
-21
-24
17
-23
-76
-57
-144
-16
-31
69
-115
22
43
EPS in ₹
1.08
3.19
2.54
2.28
3.10
2.84
2.26
2.88
3.46
0.16
5.04
275.74
0.25
-2.94
2.16
0.61
1.41
0.07
-3.53
-2.89
-1.65
-1.07
4.31
4.32
0.12
-3.95
-3.04
-3.34
2.46
-3.31
-10.72
-8.11
-20.43
-2.23
-4.38
9.85
-16.33
3.05
6.16
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,222
1,342
1,503
3,108
3,030
3,025
3,119
3,122
2,886
2,864
Fixed Assets
396
381
468
555
789
829
850
963
1,236
1,165
Current Assets
545
597
687
2,212
1,852
1,505
1,305
1,374
1,293
1,406
Capital Work in Progress
119
233
247
236
90
331
568
494
148
122
Investments
35
111
89
979
1,042
668
520
390
41
44
Other Assets
672
617
698
1,338
1,109
1,198
1,181
1,275
1,462
1,532
Total Liabilities
1,222
1,342
1,503
3,108
3,030
3,025
3,119
3,122
2,886
2,864
Current Liabilities
205
251
302
296
272
348
372
310
389
488
Non Current Liabilities
69
64
70
50
27
30
50
140
113
81
Total Equity
947
1,027
1,131
2,762
2,732
2,647
2,697
2,672
2,384
2,295
Reserve & Surplus
929
1,009
1,112
2,748
2,718
2,633
2,683
2,658
2,370
2,281
Share Capital
18
18
18
14
14
14
14
14
14
14
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-21
-9
-0
653
-619
-98
-151
42
62
-30
Investing Activities
-62
-87
-132
1,648
-323
-36
-73
104
241
60
Operating Activities
88
117
141
-66
-251
-42
-33
-158
-117
-42
Financing Activities
-47
-39
-9
-930
-45
-21
-45
96
-62
-48
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
70.21 %
70.22 %
70.22 %
70.22 %
70.22 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.83 %
0.00 %
0.90 %
0.89 %
0.94 %
DIIs
8.49 %
8.49 %
8.49 %
8.49 %
8.49 %
8.38 %
7.55 %
8.20 %
8.16 %
7.39 %
10.32 %
9.29 %
11.27 %
11.58 %
11.67 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
30.48 %
30.39 %
30.50 %
30.27 %
29.81 %
29.95 %
30.17 %
30.99 %
30.91 %
26.86 %
15.80 %
15.63 %
15.12 %
14.80 %
14.58 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,761.60 4,32,996.00 38.63 49,887.17 12.06 9,648 27.35 38.75
Cipla
1,492.70 1,21,413.90 26.30 26,520.66 14.17 4,155 12.95 43.31
Mankind Pharma
2,580.60 1,04,654.95 49.48 10,615.63 19.57 1,942 28.89 47.67
Dr Reddys Laboratories
1,208.65 1,00,877.11 18.90 28,905.40 12.36 5,578 -9.47 35.73
Zydus Life Science
953.00 97,096.55 22.70 19,831.50 13.82 3,831 14.57 37.71
Lupin
2,036.00 96,133.96 36.60 20,141.50 19.94 1,936 73.52 39.79
Aurobindo Pharma
1,227.45 72,750.14 19.95 29,559.25 17.55 3,169 8.65 24.46
Alkem Laboratories
5,484.40 65,412.22 30.08 12,978.42 9.84 1,811 14.16 35.95
Glenmark Pharmaceuticals
1,521.45 42,125.05 - 12,653.09 6.58 -1,831 675.84 38.07
IPCA Laboratories
1,566.15 40,769.00 60.71 7,829.81 22.92 529 80.05 49.85

Corporate Action

Technical Indicators

RSI(14)
Neutral
55.81
ATR(14)
Less Volatile
43.88
STOCH(9,6)
Neutral
34.08
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-10.53
ADX(14)
Strong Trend
47.26
UO(9)
Bearish
31.89
ROC(12)
Downtrend And Accelerating
-2.86
WillR(14)
Neutral
-79.65
Bearish
5
Neutral
2
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Technical Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.